Connect with us

Hi, what are you looking for?


SII advised to prioritise India’s vaccine needs, urging other international locations to wait and see, says Adar Poonawalla


Contemporary Delhi: Adar Poonawalla, CEO of vaccine valuable Serum Institute of India (SII), on Sunday entreated other international locations to wait and see as they await the offers of COVID-19 vaccine, Covishield, as the firm has been directed to prioritise the needs of India.

Other than making efforts to meet the necessities of India, the firm is additionally attempting its most attention-grabbing to stability the needs of the remaining of the realm, he added.

“We are attempting our most attention-grabbing”, Poonawalla added in the tweet.

On February 15, the World Health Organisation (WHO) listed two variations of the AstraZeneca/Oxford COVID-19 vaccine for emergency instruct, giving the inexperienced light for these vaccines to be rolled out globally via COVAX.

The vaccines are produced by AstraZeneca-SKBio (Republic of Korea) and the Serum Institute of India.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like


Chamoli, Uttarakhand:  As rescue operation is underway at the tunnel where 39 people are trapped, Uttarakhand Director General of Police (DGP) Ashok Kumar on Tuesday said it...


India’s energy demands will increase more than those of any other country over the next two decades, underlining the country’s importance to global efforts...


Leaders from across parties bid an emotional farewell to senior Congress leader Ghulam Nabi Azad on his retirement from the Rajya Sabha. Mentioning Pakistan...


Tehran:  A member of the armed forces is suspected of involvement in last November’s assassination near Tehran of Iran’s top nuclear scientist Mohsen Fakhrizadeh,...